Artificial Intelligence is helping UC Davis Health predict which patients may need immediate care and eventually keep them ...

As healthcare organizations navigate large-scale EHR transitions in 2025, patient access is gaining renewed attention, not ...

The first patient has been dosed with [212Pb]VMT01 in a phase 1/2a trial evaluating the safety of the agent in patients with melanoma. The first patient has been dosed with [212 Pb]VMT01 — a targeted ...

today announced that the first patient has been dosed in the Phase 1 EXCELERIZE clinical study evaluating REC-3565 for the treatment of relapsed or refractory B-cell lymphomas. "REC-3565 showed ...

The first patient has been dosed in a phase 2b trial evaluating the first-in-class agent Halneuron for those with neuropathic pain following chemotherapy. The first patient has been dosed in the phase ...

The Drug Allergy History Tool, which relies on patient symptom reporting, has strong reliability when compared with EHR drug allergy information.

A new study led by Dr. Maram Khazen from The Max Stern Yezreel Valley College and Prof. Adam Rose from the Faculty of ...

Mahnaz Fatahzadeh is recognized by Rutgers for her efforts to provide future health care providers with foundational ...

Five years after the first COVID-19 case in Nevada, patient zero Ron Pipkins reflects on his journey from illness to recovery, sharing insights on faith, loss, and the pandemic's lasting impact.

The man’s doctors reported this week that he was the first person in the world to be ... with the sixth and most current patient being a man in his 40s from New South Wales.

First Patient Treated with HG-CT-1 CAR-T Therapy Passes Initial Safety Tests Hemogenyx Pharmaceuticals plc is pleased to announce that the first patient has been successfully treated as part of ...

Adventist HealthCare Fort Washington Medical Center has been recognized for its efforts to drive down patient waiting times ...